Emodin negatively affects the phosphoinositide 3-kinase/AKT signalling pathway: A study on its mechanism of action

International Journal of Biochemistry and Cell Biology

Volumn 39, Issue 1, 2007, Pages 227-237

  Olsen, Birgitte B ^a   Bjørling Poulsen, Marina ^a   Guerra, Barbara ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

AKT; CK2; Emodin; mTOR; PI3K pathway

Indexed keywords

CASEIN KINASE II; EMODIN; ENZYME INHIBITOR; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; POLYPHENOL; PROTEIN KINASE B;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER THERAPY; CHROMOSOME 10; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CASEIN KINASE II; EMODIN; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 33749607802     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2006.08.006     Document Type: Article

References (29)

1. Aikin R., Maysinger D., and Rosenberg L. Cross-talk between phosphatidylinositol 3-kinase/AKT and c-Jun NH2-terminal kinase mediates survival of isolated human islets. Endocrinology 145 (2004) 4522-4531
2. Alessi D., James S.R., Downes C.P., et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr. Biol. 7 (1997) 261-269
3. Chang C.H., Lin C.C., Yang J.J., et al. Anti-inflammatory effects of emodin from Ventilago leiocarpa. Am. J. Chin. Med. 24 (1996) 139-142
4. Datta S.R., Brunet A., and Greenberg M.E. Cellular survival: A play in three Akts. Genes Dev. 13 (1999) 2905-2927
5. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 103 (2000) 239-252
6. Di Maira G., Salvi M., Arrigoni G., et al. Protein kinase CK2 phosphorylates and upregulates AKT/PKB. Cell Death Diff. 12 (2005) 668-677
7. Huang H.C., Chang J.H., Tung S.F., et al. Immunosuppressive effect of emodin, a free radical generator. Eur. J. Pharmacol. 211 (1992) 359-364
8. Huang Q., Shen H.M., and Ong C.N. Emodin inhibits tumor cell migration through suppression of the phosphatidylinositol 3-kinase-Cdc42/Rac1 pathway. Cell Mol. Life Sci. 62 (2005) 1167-1175
9. Jayasuriya H., Koonchanok N.M., Geahlen R.L., et al. Emodin, a protein tyrosine kinase inhibitor from Polygonum cuspidatum. J. Nat. Prod. 55 (1992) 696-698
10. Kim K.Y., Shin H.K., Lee J.H., et al. Cilostazol enhances casein kinase 2 phosphorylation and suppresses tumour necrosis factor-alpha-induced increased phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and apoptotic cell death in SK-N-SH cells. J. Pharmacol. Exp. Ther. 308 (2004) 97-104
11. Lai G.H., Zhang Z., and Sirica A.E. Celecoxib acts in a cyclooxygenase-2-independent manner and in synergy with emodin to suppress rat choloangiocarcinoma growth in vitro through a mechanism involving enhanced AKT inactivation and increased activation of caspase-9 and -3. Mol. Cancer Ther. 2 (2003) 265-271
12. Landesman-Bollag E., Romieu-Mourez R., Song D.H., et al. Protein kinase CK2 in mammary gland tumorigenesis. Oncogene 20 (2001) 3247-3257
13. Miller S.J., Lou D.Y., Seldin D.C., et al. Direct identification of PTEN phosphorylation sites. FEBS Lett. 528 (2002) 145-153
14. Osaki M., Oshimura M., and Ito H. PI3K-AKT pathway: Its functions and alterations in human cancers. Apoptosis 9 (2004) 667-676
15. Rennefarht U., Janakiraman M., Öllinger R., et al. Stress kinase signaling in cancer: Fact or fiction?. Cancer Lett. 217 (2005) 1-9
16. Sarbassov D.D., Guertin D.A., Siraj M.A., et al. Phosphorylation and regulation of AKT/PKB by the Rictor-mTOR complex. Science 307 (2005) 1098-1101
17. Seeber S., Issinger O.G., Holm T., et al. Validation of protein kinase CK2 as oncological target. Apoptosis 10 (2005) 875-885
18. Seldin D.C., and Leder P. Casein kinase II alpha transgene-induced murine lymphoma: Relation to theileriosis in cattle. Science 276 (1995) 834-836
19. Shieh D.-E., Chen Y.-Y., Yen M.-H., et al. Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells. Life Sci. 74 (2004) 2279-2290
20. Srinivas G., Anto R.J., Srinivas P., et al. Emodin induces apoptosis of human cervical cancer cells through poly(ADP-ribose) polymerase cleavage and activation of caspase-9. Eur. J. Pharm. 473 (2003) 117-125
21. Su Y.T., Chang H.L., Shyue S.K., et al. Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signalling pathway. Biochem. Pharmacol. 70 (2005) 229-241
22. Torres J., and Pulido R. The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. J. Biol. Chem. 276 (2001) 993-998
23. Unger G.M., Davis A.T., Slaton J.W., et al. Protein kinase CK2 as regulator of cell survival: Implications for cancer therapy. Curr. Cancer Drug Targets 4 (2004) 77-84
24. Vazquez F., Ramaswamy S., Nakamura N., et al. Phosphorylation of the PTEN tail regulates protein stability and function. Mol. Cell. Biol. 20 (2000) 5010-5018
25. Wang H.H., and Chung J.G. Emodin-induced inhibition of growth and DNA damage in the Helicobacter pylori. Curr. Microbiol. 35 (1997) 262-266
26. Wang G., Unger G., Ahmad K.A., et al. Down-regulation of CK2 induces apoptosis in cancer cells-A potential approach to cancer therapy. Mol. Cell Biochem. 274 (2005) 77-84
27. Yao R., and Cooper G.M. Requirement for phosphatidylinositol-3-kinase in the prevention of apoptosis by nerve growth factor. Science 267 (1995) 2003-2006
28. Yim H., Lee Y.H., Lee C.H., et al. Emodin, an anthraquinone derivative isolated from the rhizomes of Rheum palmatum, selectively inhibits the activity of casein kinase II as a competitive inhibitor. Planta Med. 65 (1999) 9-13
29. Zhang L., Lau Y.K., Xia W., et al. Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitises these cells to the inhibitory effect of paclitaxel. Clin. Cancer Res. 5 (1999) 343-353